GDOCGoldman Sachs Future Health Care Equity ETF

Grow my money4y track recordRanked #2,542 of 2,960 in this goal

Seeks long-term growth of capital.

By Goldman Sachs · Launched 2021

Annual Cost

0.75%

#3,765 of 5,562 · expensive

Fund Size

$20M

#4,350 of 5,562 · small

Return (1Y)Goal

+6.6%

Track Record

4 years

#2,540 of 5,562 · seasoned

Performance

Total-return NAV · USD

Growth of $10,000

$10,626+6.3%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Cap

Multi cap

Strategy

Active selection

Sector

Health care

Focus

Biotech & Genomics

What it actually holds

By weight

Concentration

Top 10 holdings = 57.1% of fundmoderately concentrated

Eli Lilly & Co

12.0%

Boston Scientific Corp

7.0%

Johnson & Johnson

6.1%

Thermo Fisher Scientific Inc

5.5%

AstraZeneca PLC

5.5%

Intuitive Surgical Inc

4.9%

Abbott Laboratories

4.6%

Argenx SE

4.1%

Insulet Corp

3.8%

Guardant Health Inc

3.5%

Asset allocation

Stocks

98.6%

Cash

1.4%

By sector

Healthcare

100.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years

Volatility (1Y)

15.8%Moderate

Year-on-year price swings

Max drawdown

-31.0%Severe

Worst peak-to-trough loss

Sharpe (3Y)

-0.15Below average

Sortino (3Y)

-0.20Moderate downside risk

Where to buy

Listing

Exchange: NYSE Arca

Full fund details

Objective: Seeks long-term growth of capital.
Strategy: Invests primarily in equity securities of U.S. and non-U.S. health care companies driving innovation in genomics, precision medicine, technology-enabled procedures, and digital healthcare. The Fund is actively managed and may invest in small- and mid-cap companies, focusing on those aligned with key health care themes.
Inception date: November 9, 2021
Fund family: Goldman Sachs